The Drug Enforcement Administration is set to once again extend a COVID-19 era rule that allows clinicians to remotely prescribe controlled medications, such as Adderall and Vicodin. The DEA is set to publish a rule on Tuesday with the Health and Human Services Department that will temporarily extend providers’ ability to remotely prescribe Schedule II-V controlled medications via telemedicine to new and existing patients through Dec. 31, 2025. Current flexibilities were set to expire at the end of this year. On Friday, an unpublished version of the rule was released on the Federal Register.
Read the full article: DEA, HHS to Extend Remote Prescribing for Another Year //
Source: https://www.modernhealthcare.com/digital-health/dea-remote-prescribing-rule-extension-2025